It almost goes without saying that economics is a rather complex area of modern civilization. But if I had to pick another equally complex areas it’d probably be either medicine or law. That’s why it really caught my attention when I saw a news story which linked all three of these together into a fascinating but quite complex whole. The article involved an investment banking firm called Laidlaw & Company and a medical research company by the name of Relmada Therapeutics. The basis of the story involved Laidlaw’s financing of research performed by Relmada. But overwhelming the entire discussion was a matter of a temporary restraining order and associated injunction issued against Laidlaw. The intent of the decision came down to preventing Laidlaw from spreading what was ruled misleading information. But personally I’m not very fond of discussion being limited in any form. Because of this I wanted to find out some answers on my own.
The best place to start seemed to be the silenced party. So with that in mind I loaded up Laidlaw’s website. What I found was an investment firm with quite the extensive history. In fact, they had such a long history that they had a timeline of their existence which rivaled what one might find in a museum. There’s a lengthy list of items which date back all the way to 1842. But what really struck me was the human element.
A company is really defined more by current leadership than history. And the site showed that Matthew Eitner and James Ahern were among the primary executive forces within the company. And I have to say, both men really impressed me. Their biographies clearly showed why Laidlaw was working with Relmada in the first place. Both gentlemen seemed intent on helping out medical research with their resources. This is the kind of invested altruism that I like to see in a company. And I have to say, it served to impress me as I continued to look into Laidlaw.